Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dewey, 1986, Cannabinoid pharmacology, Pharmacol Rev, 38, 151
Devane, 1988, Determination and characterization of a cannabinoid receptor in rat brain, Mol Pharmacol, 34, 605
Mechoulam, 1992, Cannabinoid geometry and biological activity, 1
Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0
Munro, 1993, Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038/365061a0
Evans, 1992, Ca2+-dependent release from rat brain of cannabinoid receptor binding activity, J Neurochem, 58, 780, 10.1111/j.1471-4159.1992.tb09787.x
Devane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126/science.1470919
Fride, 1993, Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent, Eur J Pharmacol, 231, 313, 10.1016/0014-2999(93)90468-W
Smith, 1994, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice, J Pharmacol Exp Ther, 270, 219
Crawley, 1993, Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents, Pharmacol Biochem Behav, 46, 967, 10.1016/0091-3057(93)90230-Q
Vogel, 1993, Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase, J Neurochem, 61, 352, 10.1111/j.1471-4159.1993.tb03576.x
Felder, 1993, Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction, Proc Natl Acad Sci, USA, 90, 7656, 10.1073/pnas.90.16.7656
Childers, 1994, Effects of anandamide on cannabinoid receptors in rat brain membranes, Biochem Pharmacol, 47, 711, 10.1016/0006-2952(94)90134-1
Bayewitch, 1995, The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling, FEBS Lett, 375, 143, 10.1016/0014-5793(95)01207-U
Mackie, 1993, Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells, Mol Pharmacol, 44, 498
Mackie, 1995, Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor, J Neurosci, 15, 6552, 10.1523/JNEUROSCI.15-10-06552.1995
Gebremedhin, 1999, Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current, Am J Physiol, 276, H2085
McAllister, 1999, Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system, J Pharmacol Exp Ther, 291, 618
Shen, 1996, Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures, J Neurosci, 16, 4322, 10.1523/JNEUROSCI.16-14-04322.1996
Vaughan, 2000, Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro, Mol Pharmacol, 57, 288
Burkey, 1997, Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain, Eur J Pharmacol, 336, 295, 10.1016/S0014-2999(97)01255-7
Breivogel, 1998, Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity, J Biol Chem, 273, 16 865, 10.1074/jbc.273.27.16865
Kearn, 1999, Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange, J Neurochem, 72, 2379, 10.1046/j.1471-4159.1999.0722379.x
Wartmann, 1995, The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide, FEBS Lett, 359, 133, 10.1016/0014-5793(95)00027-7
Liu, 2000, Functional CB1 cannabinoid receptors in human vascular endothelial cells, Biochem J, 346, 835, 10.1042/0264-6021:3460835
Melck, 1999, Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells, FEBS Lett, 463, 235, 10.1016/S0014-5793(99)01639-7
Derkinderen, 2001, Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus, J Neurochem, 77, 957, 10.1046/j.1471-4159.2001.00333.x
Rueda, 2000, The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase, Mol Pharmacol, 58, 814, 10.1124/mol.58.4.814
Derkinderen, 1996, Regulation of a neuronal form of focal adhesion kinase by anandamide, Science, 273, 1719, 10.1126/science.273.5282.1719
Gomez del Pulgar, 2000, The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt, Biochem J, 347, 369, 10.1042/0264-6021:3470369
Shivachar, 1996, Anandamide- and Δ9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride], Biochem Pharmacol, 51, 669, 10.1016/S0006-2952(95)02248-1
Berdyshev, 1997, Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells, Eur J Pharmacol, 330, 231, 10.1016/S0014-2999(97)01007-8
Sugiura, 1996, 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma × glioma hybrid NG108-15 cells, Biochem Biophys Res Commun, 229, 58, 10.1006/bbrc.1996.1757
Sugiura, 1999, Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure–activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds, J Biol Chem, 274, 2794, 10.1074/jbc.274.5.2794
Sugiura, 2000, Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells, J Biol Chem, 275, 605, 10.1074/jbc.275.1.605
Mombouli, 1999, Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells, Br J Pharmacol, 126, 1593, 10.1038/sj.bjp.0702483
Fimiani, 1999, Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release, Cell Signal, 11, 189, 10.1016/S0898-6568(98)00060-6
Venance, 1995, Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes, Nature, 376, 590, 10.1038/376590a0
Boger, 1999, Arachidonic acid amide inhibitors of gap junction cell–cell communication, Bioorg Med Chem Lett, 9, 1151, 10.1016/S0960-894X(99)00148-1
Guan, 1997, The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells, J Cell Biol, 139, 1785, 10.1083/jcb.139.7.1785
Boger, 1998, Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide, Proc Natl Acad Sci, USA, 95, 4810, 10.1073/pnas.95.9.4810
Chaytor, 1999, The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication, J Physiol, 520, 539, 10.1111/j.1469-7793.1999.00539.x
Stefano, 1996, Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes, J Biol Chem, 271, 19 238, 10.1074/jbc.271.32.19238
Prevot, 1998, Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation, Brain Res, 790, 236, 10.1016/S0006-8993(98)00066-3
Stefano, 1998, Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase, J Cardiovasc Pharmacol, 31, 813, 10.1097/00005344-199806000-00003
Molina-Holgado, 1997, Anandamide suppresses nitric oxide and TNF-α responses to Theiler's virus or endotoxin in astrocytes, Neuroreport, 8, 1929, 10.1097/00001756-199705260-00027
De Petrocellis, 1998, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation, Proc Natl Acad Sci, USA, 95, 8375, 10.1073/pnas.95.14.8375
Melck, 2000, Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation, Endocrinology, 141, 118, 10.1210/endo.141.1.7239
De Petrocellis, 2000, Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders, Chem Phys Lipids, 108, 191, 10.1016/S0009-3084(00)00196-1
Valk, 1997, Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells, Blood, 90, 1448, 10.1182/blood.V90.4.1448
Derocq, 1998, The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines, FEBS Lett, 425, 419, 10.1016/S0014-5793(98)00275-0
Calignano, 2000, Bidirectional control of airway responsiveness by endogenous cannabinoids, Nature, 408, 96, 10.1038/35040576
Mallet, 1996, The endogenous cannabinoid receptor agonist anandamide impairs memory in rats, Behav Pharmacol, 7, 276, 10.1097/00008877-199605000-00008
Terranova, 1995, Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors, Naunyn Schmiedebergs Arch Pharmacol, 352, 576, 10.1007/BF00169393
Randall, 1996, An endogenous cannabinoid as an endothelium-derived vasorelaxant, Biochem Biophys Res Commun, 229, 114, 10.1006/bbrc.1996.1766
White, 1977, A comparison of EDGF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery, Br J Pharmacol, 122, 1573, 10.1038/sj.bjp.0701546
Plane, 1997, Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries, Br J Pharmacol, 121, 1509, 10.1038/sj.bjp.0701361
Pratt, 1998, N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor, Am J Physiol, 274, H375
Wagner, 1999, Mesenteric vasodilation mediated by endothelial anandamide receptors, Hypertension, 33, 429, 10.1161/01.HYP.33.1.429
Williams, 1999, Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors, Psychopharmacology (Berl), 143, 315, 10.1007/s002130050953
Hao, 2000, Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice, Eur J Pharmacol, 392, 147, 10.1016/S0014-2999(00)00059-5
Calignano, 1998, Control of pain initiation by endogenous cannabinoids, Nature, 394, 277, 10.1038/28393
Harris, 2000, Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo, Neuroreport, 11, 2817, 10.1097/00001756-200008210-00041
Varga, 1995, Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide, Eur J Pharmacol, 278, 279, 10.1016/0014-2999(95)00181-J
Varga, 1996, Mechanism of the hypotensive action of anandamide in anesthetized rats, Hypertension, 28, 682, 10.1161/01.HYP.28.4.682
Lake, 1997, Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors, J Pharmacol Exp Ther, 281, 1030
Calignano, 1997, Potentiation of anandamide hypotension by the transport inhibitor, AM404, Eur J Pharmacol, 337, R1, 10.1016/S0014-2999(97)01297-1
Garcia, 2001, Systemic and portal hemodynamic effects of anandamide, Am J Physiol Gastrointest Liver Physiol, 280, G14, 10.1152/ajpgi.2001.280.1.G14
Schuel, 1994, Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction, Proc Natl Acad Sci, USA, 91, 7678, 10.1073/pnas.91.16.7678
Molina-Holgado, 1998, The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway, FEBS Lett, 433, 139, 10.1016/S0014-5793(98)00851-5
Song, 2000, CB1 cannabinoid receptor-mediated cell migration, J Pharmacol Exp Ther, 294, 204
Zygmunt, 1999, Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, 400, 452, 10.1038/22761
De Petrocellis, 2001, The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase, J Neurochem, 77, 1660, 10.1046/j.1471-4159.2001.00406.x
De Petrocellis, 2001, The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism, J Biol Chem, 276, 12 856, 10.1074/jbc.M008555200
Ross, 2001, Structure–activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens, Br J Pharmacol, 132, 631, 10.1038/sj.bjp.0703850
Tognetto, 2001, Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation, J Neurosci, 21, 1104, 10.1523/JNEUROSCI.21-04-01104.2001
Olah, 2001, Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1, J Biol Chem, 276, 31 163, 10.1074/jbc.M101607200
Smart, 2000, The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1), Br J Pharmacol, 129, 227, 10.1038/sj.bjp.0703050
Sarker, 2000, Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3, FEBS Lett, 472, 39, 10.1016/S0014-5793(00)01425-3
Maccarrone, 2000, Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors, J Biol Chem, 275, 31 938, 10.1074/jbc.M005722200
Johnson, 1993, Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding, Prostaglandins Leukot Essent Fatty Acids, 48, 429, 10.1016/0952-3278(93)90048-2
Oz, 2000, Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes, Eur J Pharmacol, 404, 13, 10.1016/S0014-2999(00)00396-4
Jarrahian, 1997, Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes, Prostaglandins Leukot Essent Fatty Acids, 57, 551, 10.1016/S0952-3278(97)90559-7
Shimasue, 1996, Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (−) -desmethoxyverapamil to L-type Ca2+ channel, Eur J Pharmacol, 296, 347, 10.1016/0014-2999(95)00826-8
Kimura, 1998, Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor, Biol Pharm Bull, 21, 224, 10.1248/bpb.21.224
Maingret, 2001, The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1, EMBO J, 20, 47, 10.1093/emboj/20.1.47
Sugiura, 1995, 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain, Biochem Biophys Res Commun, 215, 89, 10.1006/bbrc.1995.2437
Mechoulam, 1995, Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem Pharmacol, 50, 83, 10.1016/0006-2952(95)00109-D
Schmid, 1990, N -acylated glycerophospholipids and their derivatives, Prog Lipid Res, 29, 1, 10.1016/0163-7827(90)90004-5
Epps, 1979, N acylethanolamine accumulation in infarcted myocardium, Biochem Biophys Res Commun, 90, 628, 10.1016/0006-291X(79)91281-6
Schmid, P. C. Krebsbach, R. J. Perry, S. R. Dettmer, T. M. Maasson, J. L. Schmid, H. H. O. Occurrence and postmortem generation of anandamide and other long-chain N -acylethanolamines in mammalian brain, FEBS Lett, 1995, 375, 117, 120, Corrigendum, FEBS Lett, 1996, 385, 124, 130
Kempe, 1996, Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue, J Biol Chem, 271, 17 287, 10.1074/jbc.271.29.17287
Felder, 1996, Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat, FEBS Lett, 393, 231, 10.1016/0014-5793(96)00891-5
Sugiura, 1996, Transacylase-mediated and phosphodiesterase-mediated synthesis of N arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine, Eur J Biochem, 240, 53, 10.1111/j.1432-1033.1996.0053h.x
Hansen, 2000, N -acylethanolamines and precursor phospholipids—relation to cell injury, Chem Phys Lipids, 108, 135, 10.1016/S0009-3084(00)00192-4
Cadas, 1997, Occurrence and biosynthesis of endogenous cannabinoid precursor, N -arachidonoyl phosphatidylethanolamine, in rat brain, J Neurosci, 17, 1226, 10.1523/JNEUROSCI.17-04-01226.1997
Berrendero, 1999, Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period, Synapse, 33, 181, 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R
Arai, 2000, Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection, Biomed Chromatogr, 14, 118, 10.1002/(SICI)1099-0801(200004)14:2<118::AID-BMC936>3.0.CO;2-O
Maccarrone, 2001, Gas chromatography–mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture, J Neurochem, 76, 594, 10.1046/j.1471-4159.2001.00092.x
Schmid, 1997, Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation, Proc Natl Acad Sci, USA, 94, 4188, 10.1073/pnas.94.8.4188
Koga, 1997, Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues, J Chromatogr B, 690, 7, 10.1016/S0378-4347(96)00391-X
Bisogno, 1999, Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function, Biochem Biophys Res Commun, 256, 377, 10.1006/bbrc.1999.0254
Di Marzo, 2000, Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease, FASEB J, 14, 1432, 10.1096/fj.14.10.1432
Pagotto, 2001, Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level, J Clin Endocrinol Metab, 86, 2687
Gonzalez, 1999, Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland, Neuroendocrinology, 70, 137, 10.1159/000054468
Di Marzo, 2001, Leptin-regulated endocannabinoids are involved in maintaining food intake, Nature, 410, 822, 10.1038/35071088
Berger, 2001, Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N -acylethanolamines in piglets, Proc Natl Acad Sci, USA, 98, 6402, 10.1073/pnas.101119098
Giuffrida, 1999, Dopamine activation of endogenous cannabinoid signaling in dorsal striatum, Nat Neurosci, 2, 358, 10.1038/7268
Leweke, 1999, Elevated endogenous cannabinoids in schizophrenia, Neuroreport, 10, 1665, 10.1097/00001756-199906030-00008
Baker, 2001, Endocannabinoids control spasticity in a multiple sclerosis model, FASEB J, 15, 300, 10.1096/fj.00-0399fje
Di Marzo, 2000, Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain, J Neurochem, 75, 2434, 10.1046/j.1471-4159.2000.0752434.x
Di Marzo, 2000, Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9-tetrahydrocannabinol-tolerant rats, J Neurochem, 74, 1627, 10.1046/j.1471-4159.2000.0741627.x
Bisogno, 1999, Biosynthesis and inactivation of N -arachidonoylethanolamine (anandamide) and N -docosahexaenoylethanolamine in bovine retina, Arch Biochem Biophys, 370, 300, 10.1006/abbi.1999.1410
Deutsch, 1997, Production and physiological actions of anandamide in the vasculature of the rat kidney, J Clin Invest, 100, 1538, 10.1172/JCI119677
Schmid, 2000, A sensitive endocannabinoid assay. The simultaneous analysis of N acylethanolamines and 2-monoacylglycerols, Chem Phys Lipids, 104, 185, 10.1016/S0009-3084(99)00124-3
Sugiura, 1996, Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N acylphosphatidylethanolamine pathway in testis: involvement of Ca2+ dependent transacylase and phosphodiesterase activities, Biochem Biophys Res Commun, 218, 113, 10.1006/bbrc.1996.0020
Beaulieu1, 2000, Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat, Eur J Pharmacol, 396, 85, 10.1016/S0014-2999(00)00226-0
Schmid, 1997, Anandamide and other N -acylethanolamines in mouse peritoneal macrophages, Chem Phys Lipids, 87, 103, 10.1016/S0009-3084(97)00032-7
Giuffrida, 2000, Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry, Anal Biochem, 280, 87, 10.1006/abio.2000.4509
Wang, 2001, Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin b-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock, Anal Biochem, 294, 73, 10.1006/abio.2001.5015
Giuffrida, 2000, Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404, Eur J Pharmacol, 408, 161, 10.1016/S0014-2999(00)00786-X
Yang, 1999, GC/MS analysis of anandamide and quantification of N -arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat, J Neurochem, 72, 1959, 10.1046/j.1471-4159.1999.0721959.x
Bisogno, 1998, Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells, Eur J Biochem, 254, 634, 10.1046/j.1432-1327.1998.2540634.x
Di Marzo, 1994, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature, 372, 686, 10.1038/372686a0
Di Marzo, 1996, Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells, Biochem J, 316, 977, 10.1042/bj3160977
Bisogno, 1997, Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes, J Biol Chem, 272, 3315, 10.1074/jbc.272.6.3315
Hansen, 1995, Glutamate stimulates the formation of N -acylphosphatidylethanolamine and N -acylethanolamine in cortical neurons in culture, Biochim Biophys Acta, 1258, 303, 10.1016/0005-2760(95)00134-X
Hansen, 1997, Characterization of glutamate-induced formation of N -acylphosphatidylethanolamine and N -acylethanolamine in cultured neocortical neurons, J Neurochem, 69, 753, 10.1046/j.1471-4159.1997.69020753.x
Wagner, 1997, Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock, Nature, 390, 518, 10.1038/37371
Pestonjamasp, 1998, Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system, Biochim Biophys Acta, 1394, 249, 10.1016/S0005-2760(98)00110-6
Basavarajappa, 1999, Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N -arachidonoylphosphatidylethanolamine in SK-N-SH cells, J Neurochem, 72, 522, 10.1046/j.1471-4159.1999.0720522.x
Walker, 1999, Pain modulation by release of the endogenous cannabinoid anandamide, Proc Natl Acad Sci, USA, 96, 12 198, 10.1073/pnas.96.21.12198
Kondo, 1998, Accumulation of various N -acylethanolamines including N -arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis, Arch Biochem Biophys, 354, 303, 10.1006/abbi.1998.0688
Kuwae, 1999, Biosynthesis and turnover of anandamide and other N -acylethanolamines in peritoneal macrophages, FEBS Lett, 459, 123, 10.1016/S0014-5793(99)01226-0
Colodzin, 1963, Enzymatic formation of fatty acid amides of ethanolamine by rat liver microsomes, Biochem Biophys Res Commun, 10, 165, 10.1016/0006-291X(63)90044-5
Bachur, 1966, Microsomal synthesis of fatty acid amides, J Biol Chem, 241, 1308, 10.1016/S0021-9258(18)96775-X
Deutsch, 1993, Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist, Biochem Pharmacol, 46, 791, 10.1016/0006-2952(93)90486-G
Devane, 1994, Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes, Proc Natl Acad Sci, USA, 91, 6698, 10.1073/pnas.91.14.6698
Kruszka, 1994, The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor, J Biol Chem, 269, 14 345, 10.1016/S0021-9258(17)36624-3
Ueda, 1995, Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide, J Biol Chem, 270, 23 823, 10.1074/jbc.270.40.23823
Katayama, 1997, Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine, Biochim Biophys Acta, 1347, 212, 10.1016/S0005-2760(97)00078-7
Kurahashi, 1997, Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase, Biochem Biophys Res Commun, 237, 512, 10.1006/bbrc.1997.7180
Katayama, 1999, Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme, Biochim Biophys Acta, 1440, 205, 10.1016/S1388-1981(99)00124-9
Schmid, 1998, Alternative pathways of anandamide biosynthesis in rat testes, Chem Phys Lipids, 92, 27, 10.1016/S0009-3084(97)00109-6
Epps, 1980, Accumulation of N -acylethanolamine glycerophospholipids in infarcted myocardium, Biochim Biophys Acta, 618, 420, 10.1016/0005-2760(80)90260-X
Hansen, 2000, Determination of the phospholipid precursor of anandamide and other N -acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons, J Neurochem, 75, 861, 10.1046/j.1471-4159.2000.0750861.x
Hansen, 2001, Accumulation of the anandamide precursor and other N -acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death, J Neurochem, 76, 39, 10.1046/j.1471-4159.2001.00006.x
Berdyshev, 2000, Stress-induced generation of N -acylethanolamines in mouse epidermal JB6 P+ cells, Biochem J, 346, 369, 10.1042/0264-6021:3460369
Schmid, 1983, Metabolism of N -acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type, J Biol Chem, 258, 9302, 10.1016/S0021-9258(17)44667-9
Sasaki, 1997, N arachidonylethanolamine (anandamide) formation from N arachidonylphosphatidyl-ethanolamine in rat brain membranes, Life Sci, 61, 1803, 10.1016/S0024-3205(97)00804-7
Petersen, 1999, N acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate, FEBS Lett, 455, 41, 10.1016/S0014-5793(99)00861-3
Moesgaard, 2000, Age dependent accumulation of N -acyl-ethanolamine phospholipids in ischemic rat brain. A 31P NMR and enzyme activity study, J Lipid Res, 41, 985, 10.1016/S0022-2275(20)32041-1
Ueda, 2001, Marked activation of the N -acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations, Biochim Biophys Acta, 1532, 121, 10.1016/S1388-1981(01)00120-2
Natarajan, 1982, N acylation of ethanolamine phospholipids in canine myocardium, Biochim Biophys Acta, 712, 342, 10.1016/0005-2760(82)90352-6
Natarajan, 1983, Biosynthesis of N -acylethanolamine phospholipids by dog brain preparations, J Neurochem, 41, 1303, 10.1111/j.1471-4159.1983.tb00825.x
Natarajan, 1986, N acylethanolamine phospholipid metabolism in normal and ischemic rat brain, Biochim Biophys Acta, 878, 32, 10.1016/0005-2760(86)90341-3
Di Marzo, 1996, Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells, Biochem Biophys Res Commun, 227, 281, 10.1006/bbrc.1996.1501
Cadas, 1996, Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP, J Neurosci, 16, 3934, 10.1523/JNEUROSCI.16-12-03934.1996
Maccarrone, 1998, Anandamide hydrolysis by human cells in culture and brain, J Biol Chem, 273, 32 332, 10.1074/jbc.273.48.32332
Deutsch, 2001, The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase, J Biol Chem, 276, 6967, 10.1074/jbc.M003161200
Koutek, 1994, Inhibitors of arachidonoyl ethanolamide hydrolysis, J Biol Chem, 269, 22 937, 10.1016/S0021-9258(17)31599-5
Schmid, 1985, Properties of rat liver N -acylethanolamine amidohydrolase, J Biol Chem, 260, 14 145, 10.1016/S0021-9258(17)38695-7
Maurelli, 1995, Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’, FEBS Lett, 377, 82, 10.1016/0014-5793(95)01311-3
Desarnaud, 1995, Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization, J Biol Chem, 270, 6030, 10.1074/jbc.270.11.6030
Watanabe, 1998, Distribution and characterization of anandamide amidohydrolase in mouse brain and liver, Life Sci, 62, 1223, 10.1016/S0024-3205(98)00052-6
Hillard, 1995, Characterization of the kinetics and distribution of N -arachidonylethanolamine (anandamide) hydrolysis by rat brain, Biochim Biophys Acta, 1257, 249, 10.1016/0005-2760(95)00087-S
Cravatt, 1996, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, 384, 83, 10.1038/384083a0
Giang, 1997, Molecular characterization of human and mouse fatty acid amide hydrolases, Proc Natl Acad Sci, USA, 94, 2238, 10.1073/pnas.94.6.2238
Ueda, 1999, An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors, FEBS Lett, 454, 267, 10.1016/S0014-5793(99)00820-0
Bornheim, 1993, The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism, Biochem Biophys Res Commun, 197, 740, 10.1006/bbrc.1993.2541
Bornheim, 1995, Microsomal cytochrome P450-mediated liver and brain anandamide metabolism, Biochem Pharmacol, 50, 677, 10.1016/0006-2952(95)00177-2
Ueda, 1995, Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist, Biochim Biophys Acta, 1254, 127, 10.1016/0005-2760(94)00170-4
Hampson, 1995, Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor, Biochim Biophys Acta, 1259, 173, 10.1016/0005-2760(95)00157-8
Edgemond, 1998, Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation, Mol Pharmacol, 54, 180, 10.1124/mol.54.1.180
Yu, 1997, Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2, J Biol Chem, 272, 21 181, 10.1074/jbc.272.34.21181
Prescott, 1983, Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate, J Biol Chem, 258, 764, 10.1016/S0021-9258(18)33114-4
Sugiura, 1994, Biological activities of N -acylethanolamine and N -acylethanolamine phosphate analogues (in Japanese), Proc Jpn Conf Biochem Lipids, 36, 71
Di Marzo, 1998, 2-Arachidonoyl-glycerol as an ‘endocannabinoid’: limelight for a formerly neglected metabolite, Biochemistry (Moscow), 63, 13
Di Marzo, 1998, ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance, Biochim Biophys Acta, 1392, 153, 10.1016/S0005-2760(98)00042-3
Sugiura, 1998, Biosynthesis and actions of anandamide and 2-arachidonoylglycerol: two endogenous cannabimimetic molecules, 380
Di Marzo, 1999, Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments, Lipids, 34, S319, 10.1007/BF02562332
Sugiura, 2000, 2-arachidonoylglycerol and the cannabinoid receptors, Chem Phys Lipids, 108, 89, 10.1016/S0009-3084(00)00189-4
Lee, 1995, Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes, J Pharmacol Exp Ther, 275, 529
Sugiura, 1997, Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells, J Biochem, 122, 890, 10.1093/oxfordjournals.jbchem.a021838
Hillard, 2000, Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol, Prostaglandins Other Lipid Mediat, 61, 3, 10.1016/S0090-6980(00)00051-4
Gonsiorek, 2000, Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide, Mol Pharmacol, 57, 1045
Sugiura, 1997, Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells, Biochem Biophys Res Commun, 233, 207, 10.1006/bbrc.1997.6425
Stella, 1997, A second endogenous cannabinoid that modulates long-term potentiation, Nature, 388, 773, 10.1038/42015
Ameri, 2000, Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices, Naunyn Schmiedebergs Arch Pharmacol, 361, 265, 10.1007/s002109900200
Kobayashi, 2001, Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells, J Biochem, 129, 665, 10.1093/oxfordjournals.jbchem.a002904
Gallily, 2000, 2-arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice, Eur J Pharmacol, 406, R5, 10.1016/S0014-2999(00)00653-1
Stefano, 2000, 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1, Pharmacol Res, 42, 317, 10.1006/phrs.2000.0702
Bisogno, 2001, The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors, Eur J Biochem, 268, 1982, 10.1046/j.1432-1327.2001.02072.x
Ouyang, 1998, Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells, Mol Pharmacol, 53, 676, 10.1124/mol.53.4.676
Paria, 1998, Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors, Biol Reprod, 58, 1490, 10.1095/biolreprod58.6.1490
Sinor, 2000, Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats, Neurosci Lett, 278, 157, 10.1016/S0304-3940(99)00922-2
Varga, 1998, Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension, FASEB J, 12, 1035, 10.1096/fasebj.12.11.1035
Mechoulam, 1998, Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid, Eur J Pharmacol, 362, R1, 10.1016/S0014-2999(98)00777-8
Jarai, 2000, Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice, Hypertension, 35, 679, 10.1161/01.HYP.35.2.679
Kondo, 1998, 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independent mechanisms, FEBS Lett, 429, 152, 10.1016/S0014-5793(98)00581-X
Huang, 1999, Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system, Zhongguo Yao Li Xue Bao, 20, 1098
Straiker, 1999, Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system, Proc Natl Acad Sci, USA, 96, 14 565, 10.1073/pnas.96.25.14565
Sugiura, 2000, Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain, Biochem Biophys Res Commun, 271, 654, 10.1006/bbrc.2000.2686
Sugiura, 2001, Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation, Neurosci Lett, 297, 175, 10.1016/S0304-3940(00)01691-8
Hasegawa-Sasaki, 1985, Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells, Biochem J, 232, 99, 10.1042/bj2320099
Gammon, 1989, Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons, J Neurochem, 53, 95, 10.1111/j.1471-4159.1989.tb07299.x
Bisogno, 1997, Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells, Biochem J, 322, 671, 10.1042/bj3220671
Sugiura, 1998, Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?, Biochem Biophys Res Commun, 243, 838, 10.1006/bbrc.1998.8187
Basavarajappa, 2000, Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons, Biochim Biophys Acta, 1535, 78, 10.1016/S0925-4439(00)00085-5
Di Marzo, 1999, Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages, Eur J Biochem, 264, 258, 10.1046/j.1432-1327.1999.00631.x
Rhee, 1997, Regulation of phosphoinositide-specific phospholipase C isozymes, J Biol Chem, 272, 15 045, 10.1074/jbc.272.24.15045
Bell, 1979, Diglyceride lipase: a pathway for arachidonate release from human platelets, Proc Natl Acad Sci, USA, 76, 3238, 10.1073/pnas.76.7.3238
Farooqui, 1990, Stimulation of mono- and diacylglycerol lipase activities by bradykinin in neural cultures, Biochem Biophys Res Commun, 166, 1001, 10.1016/0006-291X(90)90910-F
Farooqui, 1993, Effect of glutamate and its analogs on diacylglycerol and monoacylglycerol lipase activities of neuron-enriched cultures, Brain Res, 604, 180, 10.1016/0006-8993(93)90366-U
Moriyama, 1999, Purification and characterization of diacylglycerol lipase from human platelets, J Biochem, 125, 1077, 10.1093/oxfordjournals.jbchem.a022389
Ueda, 1993, A possible pathway of phosphoinositide metabolism through EDTA-insensitive phospholipase A1 followed by lysophosphoinositide-specific phospholipase C in rat brain, J Neurochem, 61, 1874, 10.1111/j.1471-4159.1993.tb09829.x
Tsutsumi, 1994, Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes, Neurochem Res, 19, 399, 10.1007/BF00967316
Tsutsumi, 1995, A lysophosphoinositide-specific phospholipase C distinct from other phospholipase C families in rat brain, Arch Biochem Biophys, 317, 331, 10.1006/abbi.1995.1171
Sugiura, 1999, Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells, Biochim Biophys Acta, 1440, 194, 10.1016/S1388-1981(99)00127-4
Bisogno, 1999, Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin, J Neurochem, 72, 2113, 10.1046/j.1471-4159.1999.0722113.x
Di Marzo, 1998, The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide, Biochem J, 331, 15, 10.1042/bj3310015
Beltramo, 2000, Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol, Neuroreport, 11, 1231, 10.1097/00001756-200004270-00018
MacCarrone, 2001, Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor, Eur J Biochem, 268, 819, 10.1046/j.1432-1327.2001.01942.x
Konrad, 1994, Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: sequential actions of diacylglycerol and monoacylglycerol lipases, Biochemistry, 33, 13 284, 10.1021/bi00249a015
Goparaju, 1998, Anandamide amidohydrolase reacting with 2-arachidonoyl-glycerol, another cannabinoid receptor ligand, FEBS Lett, 422, 69, 10.1016/S0014-5793(97)01603-7
Goparaju, 1999, Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors, Biochem Pharmacol, 57, 417, 10.1016/S0006-2952(98)00314-1
Kanoh, 1986, Immunological characterization of sn -1,2-diacylglycerol and sn -2-monoacylglycerol kinase from pig brain, J Biol Chem, 261, 5597, 10.1016/S0021-9258(19)57256-8
Shim, 1989, The purification and properties of monoacylglycerol kinase from bovine brain, Biochem. Cell Biol, 67, 233, 10.1139/o89-035
Simpson, 1991, Swiss 3T3 cells preferentially incorporate sn -2-arachidonoyl monoacylglycerol into sn -1-stearoyl-2-arachidonoyl phosphatidylinositol, J Biol Chem, 266, 15 902, 10.1016/S0021-9258(18)98494-2
Kozak, 2000, Oxygenation of the endocannabinoid, 2-Arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2, J Biol Chem, 275, 33 744, 10.1074/jbc.M007088200
Moody, 2001, Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase, Biochemistry, 40, 861, 10.1021/bi002303b
Schmid, 2000, Pathways and mechanisms of N -acylethanolamine biosynthesis: can anandamide be generated selectively?, Chem Phys Lipids, 108, 71, 10.1016/S0009-3084(00)00188-2
Fride, 1995, Low doses of anandamides inhibit pharmacological effects of Δ9-tetrahydrocannabinol, J Pharmacol Exp Ther, 272, 699
Wilson, 2001, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses, Nature, 410, 588, 10.1038/35069076
Kreitzer, 2001, Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells, Neuron, 29, 717, 10.1016/S0896-6273(01)00246-X
Ohno-Shosaku, 2001, Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals, Neuron, 29, 729, 10.1016/S0896-6273(01)00247-1
Kagota, 2001, 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor, Eur J Pharmacol, 415, 233, 10.1016/S0014-2999(01)00833-0
Chen, 2000, Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1, Circ Res, 87, 323, 10.1161/01.RES.87.4.323
Derocq, 1995, Cannabinoids enhance human B-cell growth at low nanomolar concentrations, FEBS Lett, 369, 177, 10.1016/0014-5793(95)00746-V